Hien Le

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

David Ball, Shalini Vinod, Scott Babington et al. · The Lancet Oncology · 2019 · 584 citations

Medicine, Oncology, Radiation Oncology +13

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

Anthony C. Nichols, Julie Theurer, Eitan Prisman et al. · The Lancet Oncology · 2019 · 462 citations

Medicine, Oncology, Surgery +10

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

David A. Palma, Eitan Prisman, Eric Berthelet et al. · JAMA Oncology · 2022 · 102 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)

Shankar Siva, Mathias Bressel, Tao Mai et al. · JAMA Oncology · 2021 · 87 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

Anthony C. Nichols, Pencilla Lang, Eitan Prisman et al. · BMC Cancer · 2020 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +10